Rockefeller Capital Management L.P. Lowers Stock Holdings in Masimo Corporation $MASI

Rockefeller Capital Management L.P. cut its position in Masimo Corporation (NASDAQ:MASI) by 41.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 86,411 shares of the medical equipment provider’s stock after selling 61,017 shares during the period. Rockefeller Capital Management L.P.’s holdings in Masimo were worth $11,239,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of MASI. Royal Bank of Canada lifted its stake in Masimo by 44.5% during the 1st quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider’s stock worth $7,311,000 after acquiring an additional 13,513 shares in the last quarter. AQR Capital Management LLC grew its position in Masimo by 136.5% in the 1st quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider’s stock valued at $1,305,000 after acquiring an additional 4,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after purchasing an additional 66 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Masimo during the first quarter worth about $220,000. Finally, Jones Financial Companies Lllp lifted its position in shares of Masimo by 1,267.1% during the first quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider’s stock worth $367,000 after purchasing an additional 2,040 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Stock Performance

Shares of MASI opened at $179.95 on Thursday. The stock has a 50 day moving average price of $178.93 and a 200 day moving average price of $162.74. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $179.99.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Finally, Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Nine analysts have rated the stock with a Hold rating, According to MarketBeat.com, Masimo has an average rating of “Hold” and a consensus target price of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.